Cancer Genetics

$5.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.44 (+7.36%) Today
-$0.60 (-9.35%) As of 1:05 PM UTC after-hours

Why Robinhood?

You can buy or sell CGIX and other stocks, options, and ETFs commission-free!

About CGIX

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. The listed name for CGIX is Cancer Genetics, Inc. Common Stock.

CEO
John A. Roberts
Employees
110
Headquarters
Rutherford, New Jersey
Founded
1999
Market Cap
55.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.05M
High Today
$6.93
Low Today
$5.37
Open Price
$5.73
Volume
4.63M
52 Week High
$17.50
52 Week Low
$1.92

CGIX Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Jun 1, Pre-Market

You May Also Like

UJAN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure